Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
218.10
+2.77 (1.29%)
Sep 16, 2026, 3:20 PM EDT - Market open
Nutex Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,494 | 1,164 | 172 | 121 | 1,237 | - | |
Market Cap Growth | 176.63% | 575.68% | 42.70% | -90.24% | - | - |
Enterprise Value | 1,636 | 1,478 | 448 | 437 | 1,484 | - |
Last Close Price | 215.33 | 164.62 | 31.69 | 27.00 | 285.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.82 | 16.45 | 3.31 | - | - | - |
Forward PE | 8.56 | 9.41 | 53.71 | - | - | - |
PS Ratio | 1.74 | 1.33 | 0.36 | 0.49 | 5.64 | - |
PB Ratio | 3.74 | 2.75 | 0.91 | 1.53 | 10.28 | - |
P/TBV Ratio | 4.10 | 3.96 | 1.67 | 5.06 | 21.46 | - |
P/FCF Ratio | 5.42 | 4.83 | 8.26 | - | 34.39 | - |
P/OCF Ratio | 5.27 | 4.69 | 7.44 | 96.06 | 24.45 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.91 | 1.69 | 0.93 | 1.76 | 6.77 | - |
EV/EBITDA Ratio | 3.22 | 3.58 | 2.86 | 26.79 | 173.52 | - |
EV/EBIT Ratio | 3.36 | 3.76 | 3.25 | - | - | - |
EV/FCF Ratio | 5.95 | 6.12 | 21.49 | - | 41.25 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.69 | 0.83 | 1.81 | 3.49 | 2.22 | 0.93 |
Debt / EBITDA Ratio | 0.69 | 0.84 | 2.14 | 14.55 | 23.19 | 0.97 |
Debt / FCF Ratio | 1.28 | 1.46 | 16.32 | - | 7.43 | 1.31 |
Net Debt / Equity Ratio | 0.28 | 0.39 | 1.59 | 3.21 | 1.94 | 0.74 |
Net Debt / EBITDA Ratio | 0.28 | 0.40 | 1.91 | 15.57 | 27.24 | 0.79 |
Net Debt / FCF Ratio | 0.52 | 0.69 | 14.37 | -30.79 | 6.48 | 1.04 |
Asset Turnover | 0.94 | 1.11 | 0.91 | 0.60 | 0.53 | 0.94 |
Inventory Turnover | 118.85 | 141.34 | 83.04 | 54.82 | 60.10 | 63.70 |
Quick Ratio | 4.79 | 3.24 | 1.79 | 1.45 | 1.69 | 4.00 |
Current Ratio | 5.00 | 3.41 | 1.90 | 1.56 | 1.79 | 4.09 |
Return on Equity (ROE) | 64.56% | 58.94% | 70.85% | -43.55% | -277.48% | 99.44% |
Return on Assets (ROA) | 33.32% | 31.18% | 16.35% | -0.19% | -0.69% | 30.90% |
Return on Invested Capital (ROIC) | 61.92% | 53.70% | 28.97% | -0.38% | -1.33% | 57.04% |
Return on Capital Employed (ROCE) | 56.80% | 51.60% | 27.50% | -0.40% | -1.20% | 48.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.20% | 6.08% | 30.24% | -37.92% | -34.34% | - |
FCF Yield | 18.44% | 20.73% | 12.10% | -6.83% | 2.91% | - |
Payout Ratio | - | - | - | - | - | 84.24% |
Buyback Yield / Dilution | -14.84% | -23.03% | -24.57% | -4.15% | -7.10% | - |